UB Paderborn / Katalog / Suche / in CDI

Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study

Journal of neurology, 2018-07, Vol.265 (7), p.1690-1697

2018

Link zum Volltext

Verfügbarkeit prüfen

The effect of intravenous immunoglobulin on neuromyelitis optica

Neurologia (Barcelona, Spain), 2013-03, Vol.28 (2), p.65

2013

Link zum Volltext

Verfügbarkeit prüfen

The relationship between inflammatory activity and brain atrophy in natalizumab treated patients

European journal of radiology, 2012-11, Vol.81 (11), p.3485-3490

2012

Link zum Volltext

Verfügbarkeit prüfen

The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands

Journal of neuroimmunology, 2010-09, Vol.226 (1), p.143-146

2010

Link zum Volltext

Verfügbarkeit prüfen

Estudio del efecto del tratamiento con inmunoglobulinas por vía intravenosa en la neuromielitis óptica

Neurología (Barcelona, Spain), 2013-03, Vol.28 (2), p.65-72

2013

Link zum Volltext

Verfügbarkeit prüfen

Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing—remitting multiple sclerosis

Multiple sclerosis, 2010-08, Vol.16 (8), p.935-941

2010

Link zum Volltext

Verfügbarkeit prüfen

Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands

Multiple sclerosis, 2010-07, Vol.16 (7), p.810-815

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b

Multiple sclerosis, 2007-11, Vol.13 (9), p.1153-1160

2007

Link zum Volltext

Verfügbarkeit prüfen

Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis

Neurology, 2007-07, Vol.69 (1), p.63

2007

Link zum Volltext

Verfügbarkeit prüfen

Corea subagudo reversible por déficit de vitamina B12

Neurología (Barcelona, Spain), 2017-06, Vol.32 (5), p.342-343

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale

European journal of neurology, 2008-03, Vol.15 (3), p.284-288

2008

Link zum Volltext

Verfügbarkeit prüfen

The effect of intravenous immunoglobulin on neuromyelitis optica

Neurología (Barcelona, English ed. ), 2013-03, Vol.28 (2), p.65-72

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of relapses over early progression of disability in multiple sclerosis patients treated with beta-interferon

Multiple sclerosis, 2008-06, Vol.14 (5), p.636-639

2008

Link zum Volltext

Verfügbarkeit prüfen

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

The New England journal of medicine, 2012-03, Vol.366 (11), p.1000-1009

2012

Link zum Volltext

Verfügbarkeit prüfen

Early abnormalities in evoked potentials and future disability in patients with multiple sclerosis

Multiple sclerosis, 2006-08, Vol.12 (4), p.521-522

2006

Link zum Volltext

Verfügbarkeit prüfen

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Journal of neurology, neurosurgery and psychiatry, 2014-08, Vol.85 (8), p.851-858

2014

Link zum Volltext

Verfügbarkeit prüfen

Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis: a HMRS study

Journal of neurology, 2003-01, Vol.250 (1), p.22-28

2003

Link zum Volltext

Verfügbarkeit prüfen

Accurate quantification methods to evaluate cervical cord atrophy in multiple sclerosis patients

Magma (New York, N.Y.), 2006-11, Vol.19 (5), p.237-246

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial

Neurology : neuroimmunology & neuroinflammation, 2022-05, Vol.9 (3)

2022

Link zum Volltext

Verfügbarkeit prüfen

Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data

Neurología (Barcelona, Spain), 2008-03, Vol.23 (2), p.73

2008

Link zum Volltext

Verfügbarkeit prüfen

High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study

Multiple sclerosis, 2002-09, Vol.8 (1_suppl), p.59-63

2002

Link zum Volltext

Verfügbarkeit prüfen

High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study

Multiple sclerosis, 2002-02, Vol.8 (1), p.59-63

2002

Link zum Volltext

Verfügbarkeit prüfen

Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing‐remitting multiple sclerosis

Brain (London, England : 1878), 2004-01, Vol.127 (1), p.89-98

2004

Link zum Volltext

Verfügbarkeit prüfen

CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis

Journal of neuroimmunology, 2009-06, Vol.211 (1), p.101-104

2009

Link zum Volltext

Verfügbarkeit prüfen

Reversible subacute chorea caused by vitamin B12 deficiency

Neurología (Barcelona, English ed. ), 2017-06, Vol.32 (5), p.342-343

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study

The effect of intravenous immunoglobulin on neuromyelitis optica

The relationship between inflammatory activity and brain atrophy in natalizumab treated patients

The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands

Estudio del efecto del tratamiento con inmunoglobulinas por vía intravenosa en la neuromielitis óptica

Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing—remitting multiple sclerosis

Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands

Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b

Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis

Corea subagudo reversible por déficit de vitamina B12

Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale

The effect of intravenous immunoglobulin on neuromyelitis optica

Effect of relapses over early progression of disability in multiple sclerosis patients treated with beta-interferon

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

Early abnormalities in evoked potentials and future disability in patients with multiple sclerosis

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis: a HMRS study

Accurate quantification methods to evaluate cervical cord atrophy in multiple sclerosis patients

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial

Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data

High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study

High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study

Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing‐remitting multiple sclerosis

CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis

Reversible subacute chorea caused by vitamin B12 deficiency

Suchergebnisse filtern